MiMedx Group Inc (MDXG)
9.215
+0.16
(+1.71%)
USD |
NASDAQ |
Nov 21, 16:00
9.215
0.00 (0.00%)
After-Hours: 17:11
MiMedx Group Price: 9.215 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 9.18 | 9.258 | 8.55 | 9.06 | 963541.0 |
| Nov 19, 2024 | 9.04 | 9.35 | 9.04 | 9.24 | 1.025M |
| Nov 18, 2024 | 9.22 | 9.49 | 8.94 | 9.14 | 1.688M |
| Nov 15, 2024 | 9.30 | 9.475 | 8.96 | 9.28 | 2.228M |
| Nov 14, 2024 | 7.99 | 9.32 | 7.72 | 9.23 | 5.289M |
| Nov 13, 2024 | 7.50 | 7.55 | 7.325 | 7.47 | 542464.0 |
| Nov 12, 2024 | 7.61 | 7.66 | 7.43 | 7.46 | 565441.0 |
| Nov 11, 2024 | 7.55 | 7.67 | 7.50 | 7.64 | 695295.0 |
| Nov 08, 2024 | 7.44 | 7.60 | 7.39 | 7.53 | 948727.0 |
| Nov 07, 2024 | 7.47 | 7.55 | 7.39 | 7.44 | 786429.0 |
| Nov 06, 2024 | 7.44 | 7.54 | 7.275 | 7.50 | 963538.0 |
| Nov 05, 2024 | 7.07 | 7.30 | 7.05 | 7.29 | 861980.0 |
| Nov 04, 2024 | 6.93 | 7.25 | 6.88 | 7.13 | 1.328M |
| Nov 01, 2024 | 6.92 | 7.14 | 6.45 | 6.93 | 1.046M |
| Oct 31, 2024 | 6.22 | 7.20 | 6.22 | 6.85 | 1.671M |
| Oct 30, 2024 | 5.80 | 5.91 | 5.69 | 5.69 | 423785.0 |
| Oct 29, 2024 | 5.83 | 5.949 | 5.80 | 5.81 | 388106.0 |
| Oct 28, 2024 | 5.92 | 6.05 | 5.82 | 5.86 | 389950.0 |
| Oct 25, 2024 | 5.75 | 5.94 | 5.75 | 5.85 | 564480.0 |
| Oct 24, 2024 | 5.64 | 5.74 | 5.64 | 5.71 | 376242.0 |
| Oct 23, 2024 | 5.68 | 5.75 | 5.585 | 5.62 | 439946.0 |
| Oct 22, 2024 | 5.67 | 5.75 | 5.64 | 5.72 | 250281.0 |
| Oct 21, 2024 | 5.78 | 5.84 | 5.69 | 5.70 | 373917.0 |
| Oct 18, 2024 | 5.87 | 5.91 | 5.77 | 5.82 | 322087.0 |
| Oct 17, 2024 | 5.83 | 5.90 | 5.75 | 5.83 | 364044.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.63
Minimum
Dec 19 2022
15.83
Maximum
Sep 08 2021
6.473
Average
6.44
Median
Sep 23 2020
Price Benchmarks
| CEL-SCI Corp | 0.6024 |
| AIM ImmunoTech Inc | 0.2115 |
| IGC Pharma Inc | 0.3561 |
| NovaBay Pharmaceuticals Inc | 0.718 |
| Protalix BioTherapeutics Inc | 1.67 |
Price Related Metrics
| PE Ratio | 15.00 |
| PS Ratio | 3.989 |
| Price to Book Value | 7.481 |
| Price to Free Cash Flow | 27.10 |
| Earnings Yield | 6.67% |
| Market Cap | 1.354B |
| Operating PE Ratio | 21.48 |
| Normalized PE Ratio | 14.95 |